Zions: Cheap Banking With Share Buybacks and Steady Loan Momentum — Tactical Long

Hook & thesis

Zions Bancorporation (ZION) is a regional bank that looks cheap relative to its earnings power and tangible capital: the shares trade near $69 and carry a P/E around low double-digits while return on equity sits in the low double digits. Management has re-accelerated buybacks and continues to generate healthy free cash flow, creating a classic value + catalyst setup for a tactical long.

My trade thesis is straightforward: the market is discounting Zions because of past loan noise and headlines, but core loan growth, a $300 million buyback target for 2026 and a stable dividend yield provide clear upside drivers. I recommend a mid-term long trade with a well-defined entry, stop and target to capture a likely rerating toward fairer multiples.

What Zions does and why the market should care

Zions Bancorporation is a bank holding company operating multiple regional bank brands across the Western U.S., including Zions Bank, Amegy, California Bank & Trust and others. The company provides full banking services and is positioned to benefit from both commercial and consumer lending activity in its footprint.

Why investors should care right now:

• Valuation is modest: the company trades at roughly 11x earnings with a price-to-book near 1.45-1.50, which implies limited expectation for growth.
• Capital-return program: the board approved another $225 million in repurchases in 2026, bringing the full-year target to $300 million - a tangible catalyst to shrink float and boost EPS.
• Cash generation: free cash flow is meaningful (around $1.2 billion reported), supporting dividends and buybacks without stretching capital ratios.

Data-backed fundamentals

Those numbers tell a consistent story: Zions earns solid returns on equity, produces meaningful free cash flow and carries conservative leverage. At roughly $69 per share the market prices limited upside, leaving room for multiple expansion back toward historical regional-bank norms if credit remains stable and buybacks continue.

Why now - catalysts that can re-rate the stock

• Share repurchases: On 05/01/2026 the board approved an additional $225 million in repurchases for the remainder of 2026, bringing the full-year target to $300 million. That is a direct EPS-accretive action and reduces supply of shares.
• Core loan growth: Management commentary and regional trends indicate improving loan pipelines; Zions' franchise is well placed in growing Western markets where mortgage and commercial activity can lift net interest income.
• Dividend stability: A regular quarterly common dividend of $0.45 supports the floor under the stock and signals capital confidence.
• Potential multiple expansion: With EPS around $6.45, even a move from ~11x to ~12x implies upside to roughly $77.40 — my mid-term target.

Trade plan (actionable)

Direction: Long

Entry: $69.06

Target: $77.40 (mid term - 45 trading days)

Stop loss: $64.00

Horizon: mid term (45 trading days). I expect the trade to play out in this period because buyback execution and the next set of quarterly disclosures — combined with a potential modest multiple expansion — should materialize within six to ten weeks. If the stock stalls but fundamentals remain intact, I will reassess and potentially roll into a longer position.

Rationale for levels

• Entry is at the recent intraday price near the current market quote to capture the existing capital structure and upcoming buyback cadence.
• Stop at $64.00 sits below the 50-day moving average (~$65.86) and recent short-term support; a break below $64 would indicate the setup is failing and possibly reflect renewed credit concerns.
• Target $77.40 is roughly EPS ($6.45) times a 12x multiple; that multiple is still conservative for a well-managed regional bank with improving loan trends and active buybacks.

Technical and sentiment context

Short interest is moderate — recent settlement data shows short interest near 6.5M shares with days to cover between roughly 3 and 4 days. Momentum indicators are neutral-to-mixed: the 10-day SMA sits slightly above the current price, the 50-day SMA is below, and RSI is near 50, signaling no extreme condition. The MACD histogram is slightly negative, which argues for cautious entry sizing rather than an aggressive all-in position.

Risks and counterarguments

No trade is without risk. The following are the primary scenarios that could invalidate the thesis:

• Credit deterioration / charge-offs: Zions took a $50 million charge-off in late 2025 tied to loan irregularities; any additional or larger-than-expected charge-offs would hit earnings and force multiple compression. Renewed credit issues are the single largest fundamental risk.
• Litigation and reputational drag: The prior charge-off triggered class-action attention. Legal costs, settlements or continued negative headlines could sap capital and investor confidence.
• CRE and regional bank sensitivity: The company remains exposed to commercial real estate and regional economic cycles. A macro shock or a further slowdown in commercial real estate could harm loan performance.
• Interest-rate driven margin pressure: While higher rates have helped NII at some banks, rate volatility can widen funding costs or push the yield curve into configurations that compress net interest margin.
• Market sentiment and sector rotation: Regional banks are sentiment-sensitive; any broad risk-off in financials can overwhelm idiosyncratic positives like buybacks.

Counterargument: One could argue that past loan irregularities are a sign of deeper underwriting or control problems and that buybacks merely paper over recurring credit issues. If future quarters reveal further charge-offs or non-performing assets rising materially, the multiple will have to compress further and this trade will fail.

That counterargument is plausible and is the chief reason for a disciplined stop. I view the $50 million charge-off as a meaningful but contained event; the company's capital ratios, free cash flow and board action on buybacks suggest management has the confidence and balance-sheet flexibility to handle legacy issues without sacrificing shareholder returns.

What would change my mind

• Significant new charge-offs or growing non-performing loans materially above guidance would change my view to bearish.
• A meaningful cut to the dividend or a sudden halt to buybacks would reduce the attractiveness of the trade.
• Conversely, stronger-than-expected loan growth and confirmed execution of the $300 million repurchase plan would make me more bullish and likely raise my target multiple beyond 12x.

Conclusion

Zions currently offers a pragmatic tactical opportunity: a low-teens ROE bank, good free cash flow and an explicit buyback program trade at a modest multiple. The set-up is not risk-free — credit and legal issues remain the principal threats — but the stock's valuation and capital-return cadence justify a medium-conviction long for the mid term.

Trade mechanics again: enter $69.06, target $77.40 (mid term - 45 trading days), stop $64.00. Keep position sizing conservative given headline risk and watch upcoming quarterly data and repurchase cadence closely.